Unlock the skills and knowledge necessary to effectively diagnose, treat, and manage osteoporosis with our comprehensive course designed for healthcare professionals. Focused on long-term care strategies, this course will equip you with the tools to reduce fracture risk and significantly improve patient outcomes. Register for this free course and take the next step toward delivering better, more informed care to those affected by osteoporosis.
1/31/2025
1/31/2026
Upon successful completion of the program, participants should be able to:
- Recognize osteoporosis as a chronic, serious disease warranting diagnosis, early intervention, and long-term management to minimize the risk of fractures.
- Apply the latest clinical practice guidelines to develop individualized osteoporosis management plans. These plans include pharmacotherapy and lifestyle interventions to slow bone loss and improve bone health.
- Implement strategies that lead to improved patient adherence in osteoporosis.
- Enhance monitoring and follow-up practices to assess treatment efficacy and improve patient progress.
The intended target audience for this program are healthcare providers who care for patients with osteoporosis, including primary care physicians (PCPs) and advanced practice professionals (nurse practitioners [NPs], physician assistants [PAs], etc.)
Arti Bhan, MD, FACE
Division Head
Endocrinology, Diabetes, Bone and Mineral Disorders
Henry Ford Health
Detroit, MI
Jennifer Kelly, DO, FACE
Endocrinologist
Division Chief, Endocrinology and Diabetes
Director, Metabolic Bone Program
Professor, Larner College of Medicine
University of Vermont
Burlington, VT
Abhishek Shrivastava, MD, DMsc, PGD
Endocrinology Royal College of Physician, FACE
Endocrinologist
R&R Hormone Clinic
India
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American College of Endocrinology (ACE) designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.
Please allow two weeks for MOC points to appear in your account on the ABIM website. Participation information will be shared.
Nurses
American College of Endocrinology DBA American Association of Clinical Endocrinology (AACE) is approved by the California Board of Registered Nursing, Provider Number 17762, is eligible for up to 2.0 contact hours.
The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflicts of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the Continuing Medical Education (CME) Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflicts of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.
All of the relevant financial relationships listed for these individuals have been mitigated. All other planners for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Planner Disclosures
Jennifer Kelly, DO
- Consultant – Radius Health; Ascendis Pharma
- Research Funding – Shire
- Speakers’ Bureau – Bone Health Osteoporosis Foundation
Abhishek Shrivastava, MD, DMsc, FACE
- Research Funding - Sanofi; Abbott; Novo Nordisk; Intas; USV
- Speakers’ Bureau - Sanofi; Astra Zeneca; Boehringer; Novo Nordisk; Abbott MSN, Dr. Reddys, Intas
Arti Bhan, MD, FACE - No relationships to disclose
Amy Ogunsunlade - No relationships to disclose
Courtney Beck - No relationships to disclose
Dan O’Sullivan - No relationships to disclose
All of the relevant financial relationships listed for these individuals have been mitigated.
Faculty Disclosures
Jennifer Kelly, DO, FACE
- Consultant – Radius Health; Ascendis Pharma
- Research Funding – Shire
- Speakers’ Bureau – Bone Health Osteoporosis Foundation
Abhishek Shrivastava, MD, DMsc, FACE
- Research Funding - Sanofi; Abbott; Novo Nordisk; Intas; USV
- Speakers’ Bureau - Sanofi; Astra Zeneca; Boehringer; Novo Nordisk; Abbott MSN, Dr. Reddys, Intas
Arti Bhan, MD, FACE – No relationships to disclose
All of the relevant financial relationships listed for these individuals have been mitigated.
This activity is supported by an educational grant from Amgen.